Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancer

Anti-Cancer Drugs

Volumn 12, Issue 5, 2001, Pages 485-487

  Tomita, Masatoshi ^a   Kurata, Hitoshi ^a   Aoki, Yoichi ^a   Tanaka, Kenichi ^a   Kazama, Jyunichiro J ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cisplatin; Hemodialysis; Ovarian cancer; Paclitaxel; Pharmacokinetics

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANISETRON; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER RECURRENCE; CASE REPORT; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEMODIALYSIS; HUMAN; NEUTROPENIA; OVARY CANCER; PRIORITY JOURNAL; THROMBOCYTOPENIA; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AREA UNDER CURVE; CISPLATIN; CYSTADENOCARCINOMA, PAPILLARY; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPENIA; OVARIAN NEOPLASMS; PACLITAXEL; RENAL DIALYSIS; THROMBOCYTOPENIA;

EID: 0034944127     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200106000-00010     Document Type: Article

References (10)

1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
2. A case report of paclitaxel administered to a patient with platinum-refractory ovarian cancer on long-term hemodialysis
3. Pharmacokinetics of paclitaxel in an anephric patient
4. Pharmacokinetics of cisplatin in a patient undergoing hemodialysis with ovarian cancer
5. Phase I clinical and pharmacokinetic study of taxol
6. Analysis of platinum in biological materials by flameless atomic absorption spectrophotometry
7. High-performance liquid chromatographic assay for taxol in human plasma and urine and pharmacokinetics in a phase I trial
8. Clinical pharmacokinetics and pharmacodynamics of paclitaxel: A 3-hour infusion versus a 24-hour infusion
9. Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients
10. Pharmacokinetics of cis-diammine-dichloroplatin in a hemodialysis patient